# L-carnitine Exercise Recovery Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/l-carnitine-exercise-recovery-randomized-trial-evidence-review
Category: evidence-review
Summary: L-carnitine Exercise Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first p
Last reviewed: 2026-06-23
Reviewed by: Migaku Evidence Review
# L-carnitine Exercise Recovery Randomized Trial: What the Evidence Says

## Quick Answer

L-carnitine Exercise Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Therapeutic potential of L-carnitine in coronary artery disease: a systematic review | systematic review | 1 | 2026-02-19 | 10.1007/s10787-025-02048-7 |
| Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. | research article | 4 | 2026-05-18 | 10.3389/fnut.2026.1775264 |

## What The Sources Report

- The results of a prior study confirmed the protective benefits of L-carnitine due to suppression of inflammation, oxidative stress, and increased autophagy (Khedr and Werida). [Werida Rehab H. (2026); evidence level 1]
- Several experimental and clinical studies have suggested that L-carnitine supplementation may confer cardiovascular benefits in CAD patients, including improved cardiac metabolism, reduced oxidative stress, attenuation of inflammatory responses, and enhanced functional outcomes (Da Silva Guimarães et al.; Dastan et al.; Lee et al.; Lee et al.; Pastoris et al.; Singhai et al.; Tarantini et al.; Xue et al.). [Werida Rehab H. (2026); evidence level 1]
- Aging is closely associated with oxidative stress, mitochondrial dysfunction, chronic inflammation, and progressive declines in muscle and cognitive function. [Wang X (2026); evidence level 4]
- Evidence on NAC suggests context-dependent effects, with supplementation improving glutathione availability, fatigue resistance, and exercise performance in individuals with low baseline glutathione, while results remain inconsistent in healthy populations. [Wang X (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For l-carnitine exercise recovery randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Werida Rehab H. (2026). Therapeutic potential of L-carnitine in coronary artery disease: a systematic review. DOI: 10.1007/s10787-025-02048-7. PMCID: PMC12995981. PMID: 41709059. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12995981/
- Wang X (2026). Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults.. DOI: 10.3389/fnut.2026.1775264. PMCID: PMC13223053. PMID: 42232577. https://pmc.ncbi.nlm.nih.gov/articles/PMC13223053/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.